Want to create an interactive transcript for this episode?
Podcast: CME
Episode: The Science Behind FcRn Antagonists: A Deep Dive Into Their Mechanism of Action
Description:
Guest: Nicholas J. Silvestri, MD
Guest: James F. Howard, Jr, MD
The burden of generalized myasthenia gravis (gMG) on patients and caregivers is substantial. Current traditional therapies are often effective in the short term but bring with them many debilitating side effects. A more targeted approach to treatment that focuses on inhibition of the neonatal FcRn receptor complex is offering an exciting and different treatment option. Join Drs. Nicholas Silvestri and James Howard, Jr, as they discuss the expanding landscape of gMG treatments.